Cargando…

OR10-03 Murine Bimagrumab Co-administration With Incretin Agonists Results In Additive Efficacy And Superior Quality Weight Loss In The Mouse Diet-induced Obesity Model

Disclosure: K. Nguyen: Employee; Self; Versanis Bio. X. Wang: None. D. Xu: None. L.B. Klickstein: Employee; Self; Versanis Bio. Stock Owner; Self; Novartis Pharmaceuticals. Bimagrumab is an activin type II receptor (ActRII) antagonist currently in phase 2b clinical development for the treatment of o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, Kevin, Wang, Xingjuan, Xu, Deming, Klickstein, Lloyd B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Adipose Tissue, Appetite, & Obesity
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555287/ http://dx.doi.org/10.1210/jendso/bvad114.009

Ejemplares similares

RF28 | PSUN198 The Dramatic Fat Mass Loss Caused by Bimagrumab is Similar in Diabetic and Non-diabetic Patients.
por: Klickstein, Lloyd, et al.
Publicado: (2022)

OR04-03 Calcitonin Receptor Expressing Neurons in the PVH Regulate Feeding Behavior
por: Gonzalez, Ian Enrique, et al.
Publicado: (2020)

MON-113 Taste Sensitivity is Related to Incretin Response to Oral Glucose Challenge, Dietary Habits and Body Composition: A Novel Link with Energy Metabolism
por: Dagdelen, Selcuk, et al.
Publicado: (2019)

OR33-03 Congenital Leptin Deficiency: Clinical Insights from the First Reported US Cases
por: Torchen, Laura C, et al.
Publicado: (2020)

OR07-03 UCP1 Expression In Human Brown Adipose Tissue Is Inversely Associated With Cardiometabolic Risk Factors
por: Kwok, T'ng Choong, et al.
Publicado: (2023)

ODP005 Molecular Characterization of Early Adipose Tissue Remodeling and Fibrosis in a Murine Model of Diet-Induced Obesity.
por: Timms, Katie, et al.
Publicado: (2022)

Acquired Brain Injury-Induced Hyperphagia and Obesity, Successfully Treated With a GLP-1 Agonist
por: Ngu, Michael, et al.
Publicado: (2021)

FRI064 The Role Of GLP-1 Receptor Agonists In The Treatment Of Pituitary And Hypothalamic Tumor Induced Obesity
por: Botero Suarez, Carlos S, et al.
Publicado: (2023)

OR33-02 The Treatment of Partial Lipodystrophy in the Setting of Neutralizing Antibody Against Metreleptin with Leptin Receptor Agonist REGN4461
por: Akinci, Baris, et al.
Publicado: (2020)

FRI057 Drug Concentrations And Dosing Considerations For Mibavademab, A Novel Leptin Receptor Agonist, In Individuals With Generalized Lipodystrophy
por: Mendell, Jeanne, et al.
Publicado: (2023)

FRI059 Long-term Follow-up On Partial Lipodystrophy Treated With Leptin Receptor Agonist Mibavademab(REGN4461)
por: Foss de Freitas, Maria Cristina, et al.
Publicado: (2023)

Timing of Onset of Adverse Events With Setmelanotide, an MC4R Agonist, in Patients With Severe Obesity Due to LEPR or POMC Deficiency
por: Clément, Karine, et al.
Publicado: (2021)

FRI058 Treatment With Mibavademab, A Novel Leptin Receptor Agonist, Is Associated With Improvement In Metabolic Parameters In Individuals With Generalized Lipodystrophy
por: Olenchock, Ben, et al.
Publicado: (2023)

FRI025 Succinate Receptor Activation Increases Respiration In Human But Not Murine Brown Adipocytes
por: McNeill, Ben T, et al.
Publicado: (2023)

FRI069 Treatment With Mibavademab, A Novel Leptin Receptor Agonist, Is Associated With Improvement In Weight And Associated Comorbidities In Congenital Leptin Deficiency
por: Ozsu, Elif, et al.
Publicado: (2023)

FRI078 Real-World Weight Loss Outcomes And Safety Of Tirzepatide, A Novel Dual GIP And GLP-1 Receptor Agonist
por: Fansa, Sima, et al.
Publicado: (2023)

SAT649 Org43553, The First Low-molecular-weight Agonist Of The Human Luteinizing Hormone Receptor Induces Leanness And Energy Expenditure In Mice
por: Lizneva, Daria, et al.
Publicado: (2023)

Laminin-α4 Is Uniquely Upregulated in Subcutaneous White Adipose Tissue in Murine and Human Models of Obesity
por: Goddi, Anna, et al.
Publicado: (2021)

A Phase 3 Trial in Participants With Obesity Due to Bardet-Biedl Syndrome or Alström Syndrome: Efficacy and Safety of the Melanocortin 4 Receptor Agonist Setmelanotide
por: Haws, Robert, et al.
Publicado: (2021)

PSUN124 Weight Loss from Combination Anti-Obesity Medications Including Glucagon-Like Peptide-1 Receptors Agonists can Approach that Achieved from Bariatric Surgery
por: Bomberg, Eric M, et al.
Publicado: (2022)

SUN-602 Weight Loss After Glucagon-Like Peptide-1 Receptor Agonist Treatment in Childhood Obesity with Diabetes and Cirrhosis Associated with a Homozygous MC4R Mutation
por: Klee, Philippe, et al.
Publicado: (2020)

FRI067 Efficacy And Safety Of Glucagon-like Peptide 1 Analogs And Agonists (aGLP1) In Overweight/Obese Patients: A Systematic Review And An Updated Network Meta-analysis
por: Silva, Caroliny Hellen, et al.
Publicado: (2023)

The Effectiveness of Adding Pharmacotherapy to Dietary Counseling for Veterans in a Veterans Health Administration Move! Weight Management Program
por: Alvarez, Diego Alcaraz, et al.
Publicado: (2021)

Safety and Tolerability of Concomitant Administration of Multiple-Dose AM833 With Semaglutide 2.4 MG for Weight Management
por: Enebo, Lone B, et al.
Publicado: (2021)

SUN-597 Healthcare Utilization Patterns Among Commercially Insured Patients with Prader-Willi Syndrome: A Retrospective Analysis of Administrative Claims
por: Butler, Merlin G, et al.
Publicado: (2020)

Antiandrogens Target TMPRSS2 and Reduce SARS-CoV-2 Virus Entry in Lung Cells
por: Leach, Damien A, et al.
Publicado: (2021)

SUN-LB020 The Role of Estradiol and Diet on the Gut Microbiome
por: Thumuluri, Deepthi, et al.
Publicado: (2019)

The Pesticide Chlorpyrifos Promotes Obesity by Inhibiting Diet-Induced Thermogenesis
por: Wang, Bo, et al.
Publicado: (2021)

SUN-101 Dysregulation of Hypothalamic Gene Expression by Soybean Oil Diets in Mice
por: Deol, Poonamjot, et al.
Publicado: (2019)

MON-LB106 The Effect of the Ketogenic Diet on Aldosterone Over 6 Weeks
por: Belany, Paul A, et al.
Publicado: (2020)

OR12-5 Sex Differences in the Response of C57bl/6 Mice To Ketogenic Diets
por: Cochran, Jesse
Publicado: (2019)

SUN-115 Role of Olfactory Marker Protein in High-Fat, Diet-Induced Obese Models
por: Oh, Ju Hun, et al.
Publicado: (2019)

PSUN83 Exploring the Role of PARP1-mediated ADP-ribosylation in Diet-induced Obesity
por: Lee Kraus, W, et al.
Publicado: (2022)

FRI012 Exploring The Role Of FFA2 In Western Diet-induced Obesity And Metabolic Changes
por: Nnyamah, Christine, et al.
Publicado: (2023)

SUN-093 Early Life Exposure to High Fat Diet Induces Extensive Changes in the Adult Brain
por: Roy, Anna, et al.
Publicado: (2019)

TNF Alpha-Induced SOX2 Expression Promotes Hepatic Steatois in Diet-Induced Obesity Model
por: Shen, Chen, et al.
Publicado: (2021)

The Effects of Diet Induced Obesity (DIO) on Skeletal Muscle Transcription in MuRF1 KO Mice
por: Marshall, Andrea Gail, et al.
Publicado: (2021)

LBSUN132 Adipocyte-specific Ablation Of Fgf23 Attenuates Diet-induced Obesity In Female Mice
por: Park, Min Young, et al.
Publicado: (2022)

RF12 | PSUN118 Diet Quality and Energy Intake Mediate the Association of Food Insecurity with Adiposity
por: Morselli, Lisa, et al.
Publicado: (2022)

FRI062 Efficacy And Durability Of A Very Low Calorie Ketogenic Diet Protocol On Cardiometabolic Parameters
por: Camajani, Elisabetta, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v6rko32umiepou6d4i3rai8goc